TB/HIV Evening Session

2007 HIV/AIDS Implementers’ Meeting
Kigali, Rwanda
Roadmap to TB/HIV sessions
Saturday June 16, 2007
14:30 to 17:00-Serena Auditorium: Concurrent Breakout
TB/HIV: Steps to Successful Integration (E4)
HIV/TB Integration In A Network Of VCT Centers In Haiti
Reynold Grand’Pierre, GHESKIO
Prevalence and Management of Tuberculosis Among HIV/AIDS Patients in Armenia
Samvel Grigoryan, National Center for AIDS Prevention
Integration of HIV and TB Services Within the District Hospital: Experiences from
the Kericho District Hospital in Kenya
Hellen Muttai, Walter Reed HIV Project
TB/HIV Public-Private Partnership For Most-at-Risk-Groups In Jakarta, Indonesia
Flora Tanujaya, Family Health International
A Model for Integration of TB and HIV Care and Treatment Services in Mulago
Hospital, Uganda
Rhoda Wanyenze, Mulago-Mbarara Teaching Hospitals’ Joint AIDS Program
Global Progress in Implementing Collaborative TB/HIV Activities — Comparison
with the 15 PEPFAR ‘Focus’ Countries
Alasdair Reid, UNAIDS
_______________________________________________________________________
Monday JUNE 18, 2007
08:45 – Jali 1 - Plenary Speech (Q2)
TB/HIV: Integration of Services & Stopping the Newest Epidemic.
By Chakaya Muhwa
10:15 Meet the Plenary Speakers: Extended Dialogue with Plenary
Speakers
Jali 2 (Press access immediately following)
14:00 to 15:30 - KIST 2 - Concurrent Breakout
WORKSHOP: Caring for the Carers: Prevention, Post-Exposure
Prophylaxis, Know Your Status, Treatment Models (U6)
Health Workers Access to HIV/TB Prevention, Testing, Treatment and Care Services:
a Pilot Study in Zimbabwe
Ethel Dauya, Biomedical Research and Training Institute
18:15 to 20:00 - Serena Banquet Hall - Concurrent Breakout
WORKSHOP: IMAI Implementation Tools and Country Examples(X3)
TB-HIV Co-management With Co-supervision and Co-sponsorship By TB and HIV
Control Programmes.
Eyerusalem Negussie, WHO
18:15 to 20:00- KIST 3- Implementer's meeting (X7)
TB/HIV Evening Session
The session will be focused on key areas in TB/HIV including improving TB diagnosis, TB
infection control and national scale up of TB HIV program activities. The session will
discuss country experiences (challenges and how they were addressed) as well as
potential activities to tackle TB diagnosis and infection control issues at the country level.
Speakers include:
Greet Venderbriel (Rwanda)
Alwyn Mwinga (Zambia)
Haileyesus Getahun (WHO)
_______________________________________________________________________
Wednesday June 20, 2007 08:30-17:30
Serena Hotel
ACCELERATE HIV/TB activities in PEPFAR focus countries.
An experience sharing meeting co-organized by the Office of
the Global AIDS Coordinator and WHO on behalf of the Global
TB/HIV Working Group of the Stop TB Partnership
2007 HIV/AIDS Implementers’ Meeting
Kigali, Rwanda
"We cannot win the battle against AIDS if we do not also fight TB" Nelson Mandela
Some key facts about tuberculosis in HIV
• TB is the commonest presenting illness among people receiving
antiretroviral treatment both in developed and developing countries.
 TB causes at least 11% of total deaths in PLHIV and as much as 60% in
some countries.
 14 million adults are co-infected with TB and HIV – 70% of them are
concentrated in Africa
 In some regions of Africa, up to 80% of adult TB patients are HIV-infected
 Globally only less than 0.5% of PLHIV were screened for TB in 2005
____________________________________________________
The following are factors that contributed to nationwide
scale-up of collaborative TB/HIV activities*:
•Setting national targets for collaborative TB/HIV activities facilitated
implementation in Kenya where between 50-67% of TB patients were
tested for HIV, and, as a result, 84-88% and 25-29% of HIV infected TB
patients had access to cotrimoxazole and ART, respectively, during the four
quarters of 2006. Similarly, setting national targets assisted the accelerated
implementation of collaborative activities in Rwanda and Malawi. It also
helps to moblise political commitment from the TB and HIV control
programs.
• Creating conducive policy environment with the development of
appropriate policy and operational guidelines, training manuals and
protocols in line to international guidelines.
•Stakeholders engagement through effective HIV/TB coordinating bodies
at all levels was useful to coordinate the national response and accelerate
the implementation.
• Expanding HIV testing facilities and allowing front line TB clinicians and
nurses to test not only TB patients but those presenting with signs and
symptoms of TB ("TB suspects") helped to achieve a 15-fold increase in the
number of TB patients tested for HIV between 2004 and 2006 in Kenya.
Similarly nationwide availability of HIV testing was the key for success in
Rwanda and Malawi.
• Intensive, continuous training and supportive supervision of health
workers contributed to the successes documented in Kenya and Rwanda.
• Implementing revised recording and reporting formats on
collaborative TB/HIV activities has contributed to the documentation of the
progress of implementation in all the countries. The importance of including
TB components in HIV registers and HIV components in TB registers was
particularly emphasized in line to international guidelines.
• Effective and constant supply of HIV test kits, drugs and other important
commodities was also crucial for accelerated implementation.
* Extracted from the report of a planning meeting co-organized by Office of the Global AIDS
Coordinator, the World Health Organization and the Bill and Melinda Gates Foundation on behalf of
the Global TB/HIV Working Group of the Stop TB Partnership on March 6-7, 2007 in Washington DC,
USA. Report available at http://www.stoptb.org/wg/tb_hiv/